Pharmaceutical Pellets Manufacturer in India

Browse pellet references by molecule, including enteric-coated, sustained-release and MUPS catalogue designations.

Rraynex product catalogue

82 pellet products

Enteric Coated Pellets • Sustained Release Pellets • MUPS Pellets • DC Granules • APIs • Intermediates

Rraynex Pharmaceuticals manufactures pharmaceutical pellets in India. Use the catalogue to shortlist molecule and formulation references for capsule or multiparticulate development.

If you are sourcing pharma pellets in bulk, use the guide below to compare release designations and prepare your specification request. Each product page has a quote form that carries the exact catalogue reference.

Discuss your pellet and MUPS requirements at CPHI India 2026. Meet Rraynex at Stall Number 1A50, 23–25 November.

Showing 9 of 82 products
PelletsAnti-inflammatory

Aspirin

Review the catalogue reference and enquire about the specification for your project.

PelletsAnti-Platelet

Clopidogrel

Review the catalogue reference and enquire about the specification for your project.

PelletsAnti-Platelet

Clopidogrel + Aspirin

Review the catalogue reference and enquire about the specification for your project.

PelletsSNRI

Duloxetine

Review the catalogue reference and enquire about the specification for your project.

PelletsAnti-Ulcerant (PPIs)

Dexlansoprazole

Review the catalogue reference and enquire about the specification for your project.

PelletsAnti-Ulcerant (PPIs)

Dexlansoprazole MUPS

Review the catalogue reference and enquire about the specification for your project.

PelletsAnti-Ulcerant (PPIs)

Esomeprazole EC

Review the catalogue reference and enquire about the specification for your project.

PelletsAnti-Ulcerant (PPIs)

Esomeprazole Magnesium Trihydrate

Review the catalogue reference and enquire about the specification for your project.

PelletsAnti-Ulcerant (PPIs)

Esomeprazole + Levosulpiride

Review the catalogue reference and enquire about the specification for your project.

Complete pellets product list

5-alpha Reductase Inhibitor

Alpha Hydroxy Acid

Alpha-Blocker + PDE5 Inhibitor

Anti-Anginal (Fatty Acid Oxidation Inhibitor)

Anti-Depressant

Anti-fungal

Anti-Hypertensive

Anti-inflammatory

Anti-Obesity

Anticoagulant (Direct Thrombin Inhibitor)

Anticonvulsant + Vitamin B12

Antifungal (Triazole)

Antilipemic Agent

Antispasmodic

Calcium Channel Blocker

Cardiovascular

Guanylate Cyclase-C Receptor Agonist

Lipase Inhibitor

Lipid Lowering

Neurokinin-1 Antagonist

Potassium-Competitive Acid Blocker (P-CAB)

Prokinetic

Prokinetic / Antipsychotic

Skeletal Muscle Relaxant

SNRI Antidepressant + Anticonvulsant

Compare pellet formulations before requesting a quote

Start with the molecule and intended dosage form. Use the release and formulation designations below to shortlist catalogue references and define what your formulation and QA teams need to review.

Pellet designations and what to verify

DesignationWhat it describesWhat to request
EC / DREnteric coating is a delayed-release approach that uses gastro-resistance.Acid-stage and subsequent release criteria, including the test conditions.
SR / ERSustained or extended release is intended to extend release over time.The target time points, test method and acceptance criteria for the proposed material.
IRImmediate release describes an intended release without deliberate delay or extension.Dissolution conditions and acceptance criteria for the intended dosage form.
DDRDual delayed release describes two intended release stages.The criteria and method for assessing each stage.
MUPSA multiple-unit pellet system describes the dosage-form architecture.Handling, pellet integrity and release after downstream processing.

Pellet references by molecule

Start with the named molecule, then confirm the required active form and release profile. Use the separate MUPS or combination reference when it fits the project.

Enteric-coated and delayed-release pellets

For an enteric project, share the intended dosage form and loading basis. Ask how the proposed material is assessed during the acid stage and after the change of medium. If you need two delayed-release stages, identify the DDR reference and specify the criteria for each stage.

Sustained-release and extended-release pellets

State the release time points and acceptance criteria your formulation team is targeting. When comparing SR or ER offers, ask about the loading basis, particle-size requirements and the method used to assess release across the intended profile.

Multiple-unit pellet systems (MUPS)

For a MUPS tablet project, describe the blending and tableting process. Ask how to assess segregation, coating integrity and changes in release after compression. Use the named MUPS reference on sample and specification requests.

From pellet specification to bulk quotation

Use the same catalogue reference in the sample request, QA review and quotation. Send your target loading basis, release requirements, planned quantity and destination. When comparing suppliers, log the proposed site, specification revision and batch documentation alongside price and delivery. Resolve differences in grade or release criteria before comparing the commercial terms.

Buyer questions

What should I compare when choosing a pharmaceutical pellets manufacturer in India?

Start with the exact product and release design. Review the proposed specification, active-content basis, product-specific quality documentation, sample qualification and commercial requirements for your intended market.

What should QA compare for EC, SR and MUPS projects?

For EC, review the acid stage and subsequent release. For SR, review the intended release across time points. For a MUPS tablet, assess the effect of downstream processing on pellet integrity and release.

Does a pellet percentage represent a finished capsule dose?

A percentage describes drug loading on the stated content basis. A finished dose also depends on the mass incorporated and the validated formulation. Milligram-labelled catalogue entries require separate clarification.

Formulation and documentation enquiries

Share the catalogue reference, intended application, target quantity and documents required for your project. Ask which specifications and supporting records are available for the proposed material.

Contact sales to confirm current product documentation and manufacturing-site scope.